A new technology is evolving lung cancer detection and treatment at Ascension Sacred Heart Bay. It’s called the ‘Ion ...
Targeted therapies, guided by molecular testing, offer significant benefits, including fewer side effects and personalization ...
Morning Overview on MSN
Crispr reveals a new way to defeat resistant lung cancer
Drug resistance has long turned some of the most advanced lung cancer therapies into temporary victories, with tumors ...
The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's drug for patients with a form of lung ...
The accelerated FDA approval of Bayer's Hyrnuo covers treatment of advanced cases of non-small cell lung cancer with HER2 ...
Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a ...
Living with lung cancer often means spending more time in waiting rooms than in the moments that matter, but a new South ...
This summer, 75-year-old Antioch Township Treasurer and Mesick resident Kathy Soerries was preparing for a family vacation to ...
Nuvalent filed a new drug application for an experimental non-small cell lung cancer treatment with the Food and Drug Administration.
Lung cancer is the leading cause of cancer-related deaths in the United States. As we start Lung Cancer Awareness Month, a new report shows where we stand on fighting against the disease, including ...
November is Lung Cancer Awareness Month, and Mercy Hospital is shining a spotlight on the life-saving power of early ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results